Resistance to high concentrations of nalidixic acid in Pseudomonas aeruginosa PAO was due to mutations in one locus designated nalA, which was mapped by transduction between hex-9001 and leu-10. The nalA mutants were cross-resistant to pipemidic acid, a nalidixic acid analog, at relatively low concentrations. Replicative DNA synthesis was resistant to both drugs in permeabilized cells of nalA mutants. A locus coding for low-level resistance to nalidixic acid, nalB, was cotransducible with pyrB, proC, and met-28. The nalB mutants were also resistant to low levels of pipemidic acid, novobiocin, and P-lactam antibiotics (e.g., carbenicillin, azlocillin, and cefsulodin), but not to other drugs, such as gentamicin, rifampin, kanamycin, or tetracycline. In nalB mutants, DNA replication showed wild-type sensitivity to nalidixic acid, whereas carbenicillin-induced filamentation required higher drug levels than in the wild-type strain. Thus, nalB mutations appear to decrease cell permeability to some antibiotics. The sensitivity of replicative DNA synthesis to nalidixic acid and novobiocin was very similar in P. aeruginosa and Escherichia coli; by contrast, the concentrations of these drugs needed to inhibit growth of P. aeruginosa were higher than those reported for E. coli by one or two orders of magnitude.
Pseudomonas aeruginosa is about 50 times more resistant to nalidixic acid (NAL) than are Escherichia coli and other enteric bacteria (12, 27) . The minimal inhibitory concentration (MIC) of NAL usually ranges between 50 and 400 Fg/ ml in P. aeruginosa wild-type strains (27) . This is an example of the intrinsic resistance of P. aeruginosa to many antibacterial agents (2) .
In E. coli, NAL inhibits replicative DNA synthesis (8, 24) ; the target is the DNA gyrase subunit A (6, 7). Here we show that in permeabilized P. aeruginosa cells, DNA replication is sensitive to NAL; the NAL concentration needed to give 50% inhibition (ID50) of DNA synthesis was very similar to that reported for permeabilized E. coli (24) . Hence, it seems that the cell envelope critically influences the different susceptibilities of these bacteria to NAL. In mutants of E. coli that are resistant to high NAL levels, the DNA gyrase is not inhibited by the drug, in most instances because of a mutation in the gyrA (formerly nalA) gene (7, 12, 33) . Mutations in the nalB locus cause low-level resistance to NAL by impeding the uptake of the drug (1, 12) . P. aeruginosa mutants of the nalA type have been found in strains PAO (9) and PAT (31) , and a nalB locus has been mapped in PAT (32) . However, the physiological implications of these mutations have not been studied. In this paper, we characterize NAL-resistant mutants of PAO genetically and physiologically; in particular, we examine their susceptibilities to pipemidic acid (PIP; an NAL analog active against P. aeruginosa [15, 27] ), novobiocin (an inhibitor of the DNA gyrase subunit B in E. coli [6, 7] ), and ,-lactam antibiotics.
Preliminary reports of this research have appeared (M. Rella and D. Haas, Experientia 36:493,1980; Soc. Gen. Microbiol. Quart. 8:134, 1981 ).
MATERIALS AND METHODS Bacterial strains, bacteriophages, and plasmids. All strains are listed in Table 1 . The phages F116L and G101 were used for transduction, phage G101c was used for strain construction, and phages E79, F116c, B3c, and B39 were used to test potential alterations of cell surface structure (13, 14) . The plasmids FP2 and R68.45 were used for conjugation (9, 10, 14) .
Media. Nutrient yeast broth, nutrient agar, minimal medium P, and minimal medium E were the same as previously described (9) (10) (11) . The concentration of amino acids was 1 mM and that of pyrimidines was 0.1 mM when used as supplements. L-broth contained (per liter): 10 g of tryptone, 5 g of yeast extract, 5 g of NaCl, and 0.2% (wt/vol) glucose (21) .
Isolation of mutants. Spontaneous or ethyl methane sulfonate-induced nalA mutants were obtained by plat- (23) , i.e., cell permeabilization with toluene and incubation in phosphate buffer, proved unsatisfactory for the assay of DNA synthesis in P. aeruginosa. The following procedure was adopted for strain PAO. An overnight culture was diluted 20-fold into 100 ml of Lbroth and grown at 37°C with good aeration to approximately 2 x 108 cells per ml. A 50-ml portion of this culture was poured into 20 ml of cold basic medium (30) , centrifuged, and washed with 7 ml of cold Lbroth (five parts) plus basic medium (two parts). All further operations were carried out at 0 to 4°C. After   PA01  PAO4  PA025  PA0177  PA0236  PA0303  PA0317  PA0372  PA0477  PA0505  PA0512  PA0513  PA0514   PA0515   PA0643  PAO963   PAO969  PA01819  PA01840  PAO6001  PA06002  PA06003  PA06004   PA06005  PA06006  PA06007   PA06008  PA06009  GMB123 VOL. 22, 1982 on June 29, 2017 by guest http://aac.asm.org/ Downloaded from centrifugation, the cells were suspended in 1.5 ml of basic medium in a centrifuge tube containing a small magnetic bar. Cold ether (1.5 ml) was mixed with the cell suspension, using gentle magnetic stirring for 30 to 45 s (longer exposure resulted in loss of DNA synthesis activity). Then 2 ml of basic medium containing 0.8 M sucrose (instead of 0.5 M sucrose) was added to the bottom of the tube. Centrifugation at 1,100 x g for 10 min separated the cells from the upper ether-containing phases. The supernatant was sucked off completely, and the cell pellet was suspended gently in 0.45 ml of basic medium. The permeabilized cells (2 x 1010 cells per ml) were kept on ice and used the same day. They contained -106 viable cells per ml as determined by plating on nutrient agar.
DNA synthesis was assayed in 1. 
RESULTS
Mapping of mutations conferring NAL and PIP resistance. (i) Mutants highly resistant to NAL (-2 mg/ml in nutrient agar or minimal medium) were obtained spontaneously at frequencies of 10-8 to 10-9. The nalA7 mutation (in strain PA0512) was mapped between hex-9001 and leu-9005 (leu-10) by FP2-mediated conjugation. The marker order was amiE hex-9001 nalA leu-9005 met-9020; the recipient strains were PA0505, PA01819, and PA01840 (data not shown). Three mutations, nalA2 (in PA0514), nalAS (in PA0515), and nalA7 (in PA0512), were mapped by transduction with phage F116L. They were all cotransducible with leu-9005 or leu-10 (0.8 to 1.4% linkage) and hex-9001 (30 to 40% linkage), but not with met-9020 or amiE (Fig. 1A) . Experiments using phage G101 confirmed these data. However, no linkage between nalA and leu-10 was detectable (Fig. 1A) in this case. All eight nalA loci examined (Table  1) (14) appears to be due to anomalous expression of NAL resistance encoded by nalA2; hex-9001+ nalA2 transductants of PA01840 grew only on nutrient agar containing NAL, but not on minimal media with NAL, which were normally used to score NAL resistance. Transductions with nalA2 or nalA7 in the donor and nalA16 in the recipient gave no (<0.3%) NAL-susceptible segregants when selection was made for Hex'.
Thus, these nal mutations are very closely linked. Based on the biochemical evidence (shown below), all mutations described here that led to high-level NAL resistance were classified as nalA.
(ii) Since nalA mutations conferred crossresistance to PIP (Table 2) , they could also be obtained by selection for PIP resistance (on nutrient agar with 50 to 100 pug of PIP per ml) in nalA+ strains (data not shown). A mutation (pip-6003) leading to increased PIP resistance (200 ,ug/ml) in the nalA mutant PA0515 (resistant to 100 ,ug of PIP per ml) was obtained and mapped near nalA (Fig. 1A) . The linkage data do not allow us to decide whether pip-6003 is allelic with, or just very close to, nalA.
(iii) Spontaneous mutants resistant to PIP (25 to 100 ,ug/ml) or low levels of NAL (500 p,g/ml) were isolated at frequencies of lo7 to 10-8.
Many of these mutants resemble genetically the nalB mutants of strain PAT described by Watson and Holloway (31) . The marker order nalB pyrB proC met-28 was the same in both strains ( Fig. 1B; 31) . In strain PAO, five mutations were tentatively grouped together in the nalB locus. (F) or G101 (G). From 400 to 600 recombinants were scored for coinheritance of unselected markers. Arrows point to the unselected marker. Map locations are taken from reference 14; closely linked markers are leu-9005, leu-9001, and leu-10, and met-9011 and met-9020 (Matsumoto, personal communication). proC and pyrB are 55% cotransducible (26) . In strains carrying the hex-9001 mutation, selection for auxotrophic markers was made on minimal medium P containing acetamide. (A) The following alleles were used to map nalA: nalA2, nalAS, and nalA7. A transductional cross, F116L. PA06003 x PA025, suggested the marker order shown, leu-10 pip-6003 nalA5. (B) The following alleles were used to map nalB: naIB4, naIBS, nalB6, nalB8, and nalB9. pyrB (23 to 48%) and proC (2 to 4%), and conjugational crosses between them yielded no NAL-susceptible progeny. The pip-6001 mutants PA06001 and PA06007 were phenotypically similar to the nalB mutants (Table 2 ), but pip-6001 gave higher cotransduction with proC (13 to 18%), and cross PA06005 (FP2+) x PA06001 produced 1.5% NAL-susceptible recombinants (selection for Met'). Hence, pip-6001 may lie between nalB and pyrB, but its precise location has not been determined.
Susceptibility of mutants to NAL, PIP, and other drugs. Six nalA mutants showed crossresistance to PIP; however, some highly NALresistant strains remained susceptible to relatively low PIP concentrations (Table 2 ). This phenomenon of incomplete cross-resistance has already been observed in E. coli (15) . The nalA2 mutation gave a fourfold reduction in the MIC of The pip-6003 mutation was unique in that it gave low-level resistance to NAL and PIP and increased susceptibility to novobiocin (Table 2) . Kropinsky et al. (18) described rough, E79-resistant mutants of strain PAO defective in lipopolysaccharide that display low-level NAL resistance. Matsumoto (14, 20) has mapped the markers eseA (E79 resistance), somA and somB (somatic 0 antigen, a lipopolysaccharide) between leu-9005 and hex-9001. Because the pip-6003 mutation was mapped in the same region (Fig. 1A) (Fig. 2A) . About 70% of the activity was dependent on added ATP, was strongly inhibited by NAL ( Fig. 2A) , and presumably is due to replicative DNA synthesis as in E. coli (23, 28) . About 30% of the activity was ATP independent, was noninhibitable by NAL (Fig. 2A) , and reflects repair synthesis (23, 28) . Strain GMB123, which is defective in DNA polymerase I (19) , lacked ATP-independent DNA synthesis almost completely (Fig. 2B) . Replicative DNA synthesis stopped after 15 to 30 min in this mutant, but inhibition by NAL occurred as in permeabilized wild-type cells (Fig. 2B and other data not shown). The proportion of ATP-independent DNA synthesis was greater in P. aeruginosa ( Fig. 2A) than in E. coli (28) . In the wild-type PAO strains, the NAL concentration required to bring about ID50 of replicative DNA synthesis was about 10 jig/ml (Table 3 ). The corresponding ID50s reported for toluenized cells of E. coli and Serratia marcescens are 13.6 and 2.6 j.g/ml, respectively (24) . Thus, in vitro the replicative DNA syntheses of these three organisms show similar sensitivities to NAL. By contrast, for growth inhibition the MICs of NAL were 50 pug/ ml in strain PAO (Table 2 ) and 1 to 3 ,g/ml in E. coli (12, 15, 27) . This implies that P. aeruginosa and E. coli differ in their permeability for NAL. PIP gave the same ID50s as NAL for replicative DNA synthesis in P. aeruginosa, but was generally a more potent growth inhibitor than was NAL (Table 2) , probably because PIP was taken up more readily. There was no obvious correlation between the genotypes of various PAO mutants and their susceptibilities to PIP, the MICs ranging from 12.5 to 50 ,ug/ml.
In vitro, replicative DNA synthesis in nalA mutants was resistant to both NAL and PIP; the pip-6003 locus conferred low-level resistance to both drugs (Table 3) . By contrast, the naiB mutations had no influence on the inhibition of replication by both drugs, and the pip-6001 locus in PA06007 did not render replicative DNA synthesis resistant to PIP (Table 3) . These results indicate that nalA and pip-6003 affect DNA synthesis, whereas the findings for naiB and pip-6001 are consistent with a reduced uptake of NAL and PIP.
Novobiocin strongly inhibited ATP-dependent synthesis in permeabilized wild-type cells (ID50 = 0.3 jig/ml); however, a biphasic inhibition curve indicated that there may exist two targets having different sensitivities to this drug (data not shown). Two nalA mutants (nalAJ2 and nalA5) had wild-type sensitivities to novobiocin in permeabilized cells. Whole cells of P. aeruginosa PA01 were intrinsically resistant to novobiocin; the MIC was approximately 400 pug/ml in minimal medium (Table 2) and >4 mg/ml in nutrient agar. These values are about 100 times higher than those reported for E. coli K-12 (4, 33) . As in the case of NAL, the resistance of P. aeruginosa to novobiocin is probably due to a permeability barrier. However, an enzymatic inactivation of NAL and novobiocin by P. aeruginosa remains possible.
Inhibition of carbenicillin-induced filamentation in a naLB mutant. Sublethal concentrations of carbenicillin induce the formation of long filaments in P. aeruginosa (5) . In liquid medium, strain PA0969 (naIB+) began to form filaments (observed in a phase-contrast microscope) at 4 ,ug of carbenicillin per ml. Carbenicillin concentrations of -4 ,ug/ml resulted in a decrease of colony-forming units, whereas the cell mass (measured by the optical density) continued to increase exponentially (Fig. 3A) . The nalB mutant PA06005 behaved similarly, but filamentation and inhibition of colony-forming units started only at 16 ,ug/ml (Fig. 3B) . Thus, it appears that a permeability barrier in the mutant prevented the antibiotic from reaching its target(s). DISCUSSION High-level NAL resistance mutations in strain PAO were characterized by several common features. (i) All mutations examined could be localized in the same chromosome region, and there was no evidence for more than one genetic locus. Thus, the previous classification into nalA and nalC loci (14) , which was essentially based on the apparent lack of linkage of nalA2 to hex, seems to be unnecessary, and we now use the symbol nalA for all high-level NAL resistance mutations mapped between hex and leu-10.
(ii) The DNA replication was NAL resistant in permeabilized cells of nalA mutants. Because we have not measured gyrase activity, the designation gyrA (now used in E. coli) was not adopted. (iii) Our nalA mutants generally showed no pleiotropic effects on the susceptibility to other antibiotics. The nalA2 mutation was exceptional; it conferred increased susceptibility to novobiocin and was reminiscent of the nalA mutation found in E. coli KL166 (4 (-) and the optical density (---). The increase in optical density was the same in all cultures regardless of carbenicillin concentration. Carbenicillin was added at time zero at the following concentrations: *, 0 ,ug/ml; 0, 2 ,ug/ml; *, 4 ,ug/ml; O, 8 pg/ml; *, 16 ,ug/ml; A, 32 ,ug/ ml; *, 64 ,ug/ml; 0, 128 ,ug/ml; and A, 256 ,ug/ml. tibility to AM-715, a NAL analog highly active against P. aeruginosa (17).
The pip-6001 and nalB mutations were pleiotropic; they affected the susceptibility to NAL, PIP, novobiocin, carbenicillin, and other 3-lactam antibiotics. The nalB8 locus (in strain PA06005), for example, caused resistance to PIP in whole cells but not in ether-permeabilized cells used for the assay of replication. Moreover, nalB8 increased the concentration of carbenicillin needed to induce filamentation. The simplest explanation for these phenotypes is that nalB8 modified cell permeability. There is evidence that outer membrane proteins can modulate the susceptibility of P. aeruginosa to 1B-lactam antibiotics (16, 22, 34) . In Salmonella and E. coli, mutations in porin genes can change the permeation of these drugs (25) . The nalB gene may therefore code for an outer membrane protein, but other explanations are also possible, e.g., alterations of penicillin-binding proteins in nalB and pip-6WI mutants. Electron microscopic pictures of nalB mutants revealed no obvious defects of the outer membrane (H. Ebersold, personal communication).
All resistance mutations studied here were chromosomal. R plasmids specifying NAL resistance have not been described in the literature (3). Mutations of the nalB type were obtained spontaneously at a high frequency (10-7 to 10-8) and may be of interest because they lead to resistance to clinically useful 3-lactam antibiotics. Bryan (2) concluded that this type of lowlevel resistance may be of greater importance than high-level resistance encoded by R plasmids in the therapy of P. aeruginosa infections.
